Pharmaceutical Spray Drying Projected to Grow at an Annualized Rate of 17%, predicts Roots Analysis

By: Roots Anlaysis
Spread the Word
Listed Under



London City - London, Greater - England


LONDON - June 26, 2018 - PRLog -- Roots Analysis has announced the addition of "Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028' (" report to its list of offerings.

Ishita Nanda, the principal analyst, stated, "Given the flexibility offered in terms of drug development and formulation, the economics of the technique, the introduction of aseptic methods, and the recent approval of the first spray dried biologic, Raplixa®, the adoption of spray drying is anticipated to increase at a steady pace."

The report presents opinions on several key aspects of the market. Among other elements, it includes:

1.     An assessment of the various players engaged in the manufacturing of spray dryers, including a detailed analysis of their products based on inlet temperature, type of nozzle, size of the dryer and atomizing gas.

2.     An overview of the current market landscape of spray drying service providers, featuring an analysis based on location of facilities, type of spray dryers used, scale of operation, information on cGMP status of facilities and availability of fill/finish services.

3.     An insightful 2X2 analysis of different spray drying service providers, based on the spray drying capabilities and the company size. Similar analysis was done for spray dryer manufacturers.

4.     A detailed analysis of the mergers and acquisitions that have taken place in this space, highlighting the trend in the number of companies acquired in the last few years.

5.     A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework.

6.     A robust forecast analysis, highlighting the future potential of pharmaceutical spray drying service market considering the trends in the pharmaceutical contract manufacturing industry, operation costs associated with spray drying and affiliated challenges and opportunities.

Nanda further added, "The technology also aids in improving the compression properties of drugs, allowing developers to design concentrated dose variants of medications and reduce tablet size. Such alterations have demonstrated the potential to improve patient compliance."

The research covers detailed profiles and assesses product portfolios of the following companies:

1.     Ajinomoto (OmniChem)

2.     Buchi Labortechnik

3.     Catalent Pharma Solutions

4.     Coriolis Pharma

5.     Evotec

6.     GEA Niro

7.     Hemraj India

8.     Hovione

9.     Idifarma

10.   Micro-Sphere

11.   Nova Laboratories

12.   Patheon

13.   SPX

14.   Techni Process

15.   Several Others

For additional details, please visit

or email

Media Contact
Gaurav Chaudhary
Posted By:*** Email Verified
Tags:Pharmaceutical, Biotechnology
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Roots Analysis PRs
Trending News
Most Viewed
Top Daily News

Most Viewed
Top Daily News
PTC News

Jun 26, 2018 News

Like PRLog?
Click to Share